Early heart rate variability evaluation enables to predict ICU patients’ outcome

por Bodenes, Laetitia, N’Guyen, Quang-Thang, Le Mao, Raphaël, Ferrière, Nicolas, Pateau, Victoire, Lellouche, François, L’Her, Erwan
Publicado 2022

Case Report: Transient cortical blindness following coronary angiography

por Oktaviono, Yudi Her, Kawilarang, Maureen Victoria, Kawilarang, Michael, Gunadi, Ruth Irena, Philothra, Petrina Theda, Al Farabi, Makhyan Jibril
Publicado 2022

Blood Coagulation on Titanium Dioxide Films with Various Crystal Structures on Titanium Implant Surfaces

por Huang, Her-Hsiung, Chen, Zhi-Hwa, Nguyen, Diem Thuy, Tseng, Chuan-Ming, Chen, Chiang-Sang, Chang, Jean-Heng
Publicado 2022

Detection of innate immune response modulating impurities (IIRMI) in therapeutic peptides and proteins: Impact of excipients

por Thacker, Seth G., Her, Cheng, Kelley-Baker, Logan, Ireland, Derek D C., Manangeeswaran, Mohanraj, Pang, Eric S., Verthelyi, Daniela
Publicado 2022

Produce prescription projects: Challenges, solutions, and emerging best practices – Perspectives from health care providers

por Stotz, Sarah A., Budd Nugent, Nadine, Ridberg, Ronit, Byker Shanks, Carmen, Her, Ka, Yaroch, Amy L., Seligman, Hilary
Publicado 2022

Soreness or sng: a common symptom with differential clinical impact from pain in degenerative lumbar spine diseases

por Chiu, Hsiao-Yean, Su, I-Wen, Yu, Yu-Wen, Chen, Yi-Chen, Chen, Chih-Cheng, Lin, Jiann-Her
Publicado 2023

Allogeneic stem cell transplantation without preconditioning in a child with therapy-related myelodysplastic syndrome: A case report

por Tung, Yi-Ling, Wang, Yi-Lun, Chang, Tsung-Yen, Chiu, Chia-Chi, Wen, Yu-Chuan, Jaing, Tang-Her
Publicado 2023

Machine learning to predict late respiratory support in preterm infants: a retrospective cohort study

por Wu, Tsung-Yu, Lin, Wei-Ting, Chen, Yen-Ju, Chang, Yu-Shan, Lin, Chyi-Her, Lin, Yuh-Jyh
Publicado 2023

Claudia Gemme, researcher at INFN in Genova, has had a varied career with the ATLAS Collaboration. From her work on the construction and commissioning of the ATLAS Pixel detector, to a career in physics analysis and the ATLAS Publication Committee, she leads a key upgrade of the ATLAS detector: the ATLAS Inner Tracker (ITk).

por Darbo, Nanni
Publicado 2020

Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy?...

por Rossi, Valentina, Berchialla, Paola, Giannarelli, Diana, Nisticò, Cecilia, Ferretti, Gianluigi, Gasparro, Simona, Russillo, Michelangelo, Catania, Giovanna, Vigna, Leonardo, Mancusi, Rossella Letizia, Bria, Emilio, Montemurro, Filippo, Cognetti, Francesco, Fabi, Alessandra
Publicado 2019

Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)

por Yamashita, Toshinari, Masuda, Norikazu, Saji, Shigehira, Araki, Kazuhiro, Ito, Yoshinori, Takano, Toshimi, Takahashi, Masato, Tsurutani, Junji, Koizumi, Kei, Kitada, Masahiro, Kojima, Yasuyuki, Sagara, Yasuaki, Tada, Hiroshi, Iwasa, Tsutomu, Kadoya, Takayuki, Iwatani, Tsuguo, Hasegawa, Hiroki, Morita, Satoshi, Ohno, Shinji
Publicado 2020

A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trial

por Schouten, Philip C., Dackus, Gwen M. H. E., Marchetti, Serena, van Tinteren, Harm, Sonke, Gabe S., Schellens, Jan H. M., Linn, Sabine C.
Publicado 2016

Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)

por Kim, Ji-Yeon, Park, Seri, Im, Seock-Ah, Kim, Sung-Bae, Sohn, Joohyuk, Lee, Keun Seok, Chae, Yee Soo, Lee, Ki Hyeong, Kim, Jee Hyun, Im, Young-Hyuck, Kim, Tae-Yong, Lee, Kyung-Hun, Ahn, Jin-Hee, Kim, Gun Min, Park, In Hae, Lee, Soo Jung, Han, Hye Sook, Kim, Se Hyun, Jung, Kyung Hae, Park, Yeon Hee
Publicado 2019

Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)

por Yamashita, Toshinari, Masuda, Norikazu, Saji, Shigehira, Araki, Kazuhiro, Ito, Yoshinori, Takano, Toshimi, Takahashi, Masato, Tsurutani, Junji, Koizumi, Kei, Kitada, Masahiro, Kojima, Yasuyuki, Sagara, Yasuaki, Tada, Hiroshi, Iwasa, Tsutomu, Kadoya, Takayuki, Iwatani, Tsuguo, Hasegawa, Hiroki, Morita, Satoshi, Ohno, Shinji
Publicado 2020

Corrigendum to ‘Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)’: [ESMO Open Volume 6, Issue 2, April 2021, 100054]

por De Angelis, C., Bruzzese, D., Bernardo, A., Baldini, E., Leo, L., Fabi, A., Gamucci, T., De Placido, P., Poggio, F., Russo, S., Forestieri, V., Lauria, R., De Santo, I., Caputo, R., Cianniello, D., Michelotti, A., Del Mastro, L., De Laurentiis, M., Giuliano, M., De Placido, S., Arpino, G.
Publicado 2021

Metabolite profiling, hypolipidemic, and anti-atherosclerosis activity of mixed vegetable fermentation extract

por Rachmawati, Ermin, Suharti, Suharti, Sargowo, Djanggan, Sekar Kinasih, Larasati, Octaviano, Yudi Her, Mutiah, Roihatul, Ismail, Mahrus, Munjin Nasih, Ahmad
Publicado 2023

Long-Term Clinical Outcomes of Drug-Coated Balloon Treatment for De Novo Coronary Lesions

por Her, Ae-Young, Kim, Bitna, Ahn, Soe Hee, Park, Yongwhi, Cho, Jung Rae, Jeong, Young-Hoon, Shin, Eun-Seok
Publicado 2023

Regenerative Effect of Mesenchymal Stem Cell on Cartilage Damage in a Porcine Model

por Lin, Sheng-Chuan, Panthi, Sankar, Hsuuw, Yu-Her, Chen, Shih-Hsien, Huang, Ming-Ju, Sieber, Martin, Hsuuw, Yan-Der
Publicado 2023

Long-Term Clinical Impact of Patients with Multi-Vessel Non-Obstructive Coronary Artery Disease

por Jung, Jin, Lee, Su-Nam, Her, Sung-Ho, Yoo, Ki-Dong, Moon, Keon-Woong, Moon, Donggyu, Jang, Won-Young
Publicado 2023

Efficacy of Pirfenidone According to Dose in Patients with Idiopathic Pulmonary Fibrosis: A Prospective, Observational, Single-Center Cohort Study

por Lee, Ho Young, Jung, So Young, Jang, Ji Hoon, Ko, Junghae, Kim, Dae-Wook, Her, Minyoung, Lee, Jae Ha
Publicado 2023